Form 4: AbbVie Director Edward J. Rapp Reports Acquisition of Stock Equivalent Units

Director Edward J. Rapp reports acquisition of AbbVie stock equivalent units through director fees credited to a grantor trust.

Summary

• On March 31, 2024, Edward J. Rapp, a director of AbbVie Inc., acquired 212 stock equivalent units.
• These units were obtained as director fees credited to a stock equivalent unit account under a grantor trust.
• The fees are generally paid in cash at age 65 or upon retirement from the board.
• The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
• The price of the stock equivalent units was $182.1.
• Following the transaction, Rapp beneficially owns 25,701 stock equivalent units, which includes units acquired through dividend reinvestment.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of a director's acquisition of stock equivalent units, which is a common practice in executive compensation.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders as it involves a director's compensation.

Key Dates